The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Tilos Therapeutics; twoXAR
Research Funding - Bayer; Bristol-Myers Squibb; Exelixis; Leap Therapeutics; Merrimack
Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.
 
Eudocia Quant Lee
Honoraria - Medlink; UpToDate
Consulting or Advisory Role - Lilly
 
Alona Muzikansky
No Relationships to Disclose
 
David A. Reardon
Honoraria - Abbvie; Bristol-Myers Squibb; Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Midatech Pharma (Inst); Tragara (Inst)
 
Jorg Dietrich
Honoraria - Monteris Medical
Consulting or Advisory Role - Monteris Medical
Patents, Royalties, Other Intellectual Property - UpToDate Author
 
Lakshmi Nayak
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Dan G. Duda
No Relationships to Disclose
 
Ugonma Nnenna Chukwueke
No Relationships to Disclose
 
Rameen Beroukhim
Consulting or Advisory Role - Gilead Sciences; IBM; Merck; Novartis
Research Funding - Gilead Sciences; Merck; Novartis; ViiV Healthcare
 
Lisa M. Doherty
Consulting or Advisory Role - Abbvie
 
Caroline Kane
No Relationships to Disclose
 
Debra C. LaFrankie
No Relationships to Disclose
 
Brittney Fontana
No Relationships to Disclose
 
Jennifer Stefanik
No Relationships to Disclose
 
Sandra Ruland
No Relationships to Disclose
 
Victoria Caruso
No Relationships to Disclose
 
Jennifer Bruno
No Relationships to Disclose
 
Sarah C. Gaffey
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Aurora Biopharma; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; Kadmon; Karyopharm Therapeutics; Lilly; Monteris Medical; Vascular Biogenics; Vivus; ZIOPHARM Oncology
Speakers' Bureau - Merck
Research Funding - Abbvie (Inst); Agios (Inst); Angiochem (Inst); ARIAD (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); ImmunoCellular Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly; Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Sanofi (Inst); Vascular Biogenics (Inst)